A recent cross-sectional study of COVID-19 recovered individuals analyzed >6 months after infection has calculated t1/2 of ∼3.5 months for CD4 and CD8 T cells detected with activation induced markers [57]. The gene discussed is CD8A; the disease is COVID-19.